Comparative evaluation of synergy of combinations of -lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae
Author(s) -
Lorenzo Drago,
L. Nicola,
Valentina Rodighiero,
Monica Larosa,
R. Mattina,
Elena De Vecchi
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkr016
Subject(s) - levofloxacin , clavulanic acid , penicillin , clarithromycin , microbiology and biotechnology , amoxicillin , streptococcus pneumoniae , antibiotics , cephalosporin , trovafloxacin , ceftriaxone , ofloxacin , medicine , antibacterial agent , pharmacology , biology , ciprofloxacin
Streptococcus pneumoniae has shown a great ability to develop efficacious mechanisms of resistance to the main drugs for the treatment of pneumonia, such as β-lactams, macrolides and fluoroquinolones. The present study aimed to compare the antipneumococcal activity of combinations of respiratory fluoroquinolones with cephalosporins (either parenteral or oral) or protected penicillin versus the standard combinations (i.e. a macrolide with a protected penicillin or cephalosporin) against 100 isolates with different susceptibilities to macrolides and/or penicillin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom